← Leaderboards
Scott C Denne
Indiana Univ-Purdue Univ At Indianapolis
$5,261,504
Attributed
$8,407,950
Total exposure
25
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.3M · FY2005–17$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$8,517,808 · 26
By mechanism
UL1$5,297,754 · 1
R01$1,825,549 · 1
KL2$691,040 · 1
TL1$304,098 · 1
S10$219,716 · 4
M01$179,651 · 18
Top collaborators
- Anantha Shekhar3 shared
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Sandra L Morzorati$1,661,710
- Catherine A Leitch$104,838
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchNutrition Related TagHuman SubjectDevelopmental NutritionPremature Infant HumanProtein MetabolismDietary AminoacidProtein BiosynthesisProteolysisResearch PersonnelBioenergeticsChild Physical DevelopmentInstitutionResourcesGestational AgeAminoacid MetabolismInfant Human (0-1 Year)GrantDietary ProteinsHuman Therapy EvaluationComputer Retrieval Of Information On Scientific Projects DatabaseFundingEssential AminoacidNutrient Intake Activity
Grant awards (53)
Indiana Clinical and Translational Sciences Institute$5,297,754
UL1 · FY2017 · TR
Indiana Clinical and Translational Sciences Institute$691,040
KL2 · FY2017 · TR
Indiana Clinical and Translational Sciences Institute$304,098
TL1 · FY2017 · TR
METABOLIC CONSEQUENCES OF GROWTH FAILURE IN EXTREMELY LOW BIRTH WEIGHT INFANTS$4,137
M01 · FY2008 · RR · contact PI
ENDOTHELIAL DYSFUNCTION IN TERM AND NEAR-TERM NEONATES WITH PULMONARY HYPERTENS$613
M01 · FY2008 · RR · contact PI
ENERGY EXPENDITURE IN INFANTS WITH HYPOPLASTIC LEFT HEART SYNDROME$140
M01 · FY2008 · RR · contact PI
RESPONSE TO ANTI-TUMOR NECROSIS FACTOR-A ANTIBODY IN CHILDREN WITH CROHN'S$29
M01 · FY2008 · RR · contact PI
Mechanisms of Neonatal Protein Accretion$307,719
R01 · FY2007 · HD · contact PI
METABOLIC CONSEQUENCES OF GROWTH FAILURE IN EXTREMELY LOW BIRTH WEIGHT INFANTS$48,694
M01 · FY2007 · RR · contact PI
ENDOTHELIAL DYSFUNCTION IN TERM AND NEAR-TERM NEONATES WITH PULMONARY HYPERTENS$7,212
M01 · FY2007 · RR · contact PI
ENERGY EXPENDITURE IN INFANTS WITH HYPOPLASTIC LEFT HEART SYNDROME$1,642
M01 · FY2007 · RR · contact PI
RESPONSE TO ANTI-TUMOR NECROSIS FACTOR-A ANTIBODY IN CHILDREN WITH CROHN'S$341
M01 · FY2007 · RR · contact PI
Mechanisms of Neonatal Protein Accretion$316,910
R01 · FY2006 · HD · contact PI
METABOLIC CONSEQUENCES OF GROWTH FAILURE IN EXTREMELY LOW BIRTH WEIGHT INFANTS$43,503
M01 · FY2006 · RR · contact PI
RESPONSE TO ANTI-TUMOR NECROSIS FACTOR-A ANTIBODY IN CHILDREN WITH CROHN'S$8,040
M01 · FY2006 · RR · contact PI
ENDOTHELIAL DYSFUNCTION IN TERM AND NEAR-TERM NEONATES WITH PULMONARY HYPERTE$5,818
M01 · FY2006 · RR · contact PI
Mechanisms of Neonatal Protein Accretion$324,536
R01 · FY2005 · HD
METABOLIC CONSEQUENCES OF GROWTH FAILURE IN EXTREMELY LOW BIRTH WEIGHT INFANTS$18,887
M01 · FY2005 · RR
RESPONSE TO ANTI-TUMOR NECROSIS FACTOR-A ANTIBODY IN CHILDREN WITH CROHN'S$8,968
M01 · FY2005 · RR
ENERGY EXPENDITURE AND PROTEIN CATABOLISM IN EXTREMELY LOW BIRTH WEIGHT INFANTS$1,491
M01 · FY2005 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$232
M01 · FY2005 · RR
Mechanisms of Neonatal Protein Accretion$324,536
R01 · FY2004 · HD
Gas Chromatograph Mass Spectrometer$109,858
S10 · FY2004 · RR
GAS CHROMATOGRAPH MASS SPECTROMETER: FETAL DEVELOPMENT$59,323
S10 · FY2004 · RR
GAS CHROMATOGRAPH MASS SPECTROMETER: PERINATAL, LOW BIRTH WEIGHT$36,253
S10 · FY2004 · RR
Metabolic Consequences of Growth Failure in Extremely Low Birth Weight Infants$18,802
M01 · FY2004 · RR
GAS CHROMATOGRAPH MASS SPECTROMETER: CROHN'S DISEASE$14,282
S10 · FY2004 · RR
Energy Expenditure and Protein Catabolism in Extremely Low birth Weight Infants$5,383
M01 · FY2004 · RR
Response to Anti-Tumor Necrosis Factor-a Antibody in Children with Crohn's$4,710
M01 · FY2004 · RR
Regulation of Neonatal Protein Accretion$1,009
M01 · FY2004 · RR
Mechanisms of Neonatal Protein Accretion$331,025
R01 · FY2003 · HD
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2002 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2002 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2002 · RR
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2001 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2001 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2001 · RR
MECHANISMS OF NEONATAL PROTEIN ACCRETION$220,823
R01 · FY2000 · HD
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2000 · RR
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2000 · RR
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2000 · RR
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2000 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2000 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2000 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2000 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2000 · RR
REGULATION OF NEONATAL PROTEIN ACCRETION$0
M01 · FY2000 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2000 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2000 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2000 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2000 · RR
TYROSINE METABOLISM IN PREMATURE INFANTS$0
M01 · FY2000 · RR
EFFECT OF INCREASE IN ENERGY OR PROTEIN ADMINISTRATION ON PROTEIN METABOLISM$0
M01 · FY2000 · RR